These are tools developed by partner organizations that are complimentary and can support the implementation of the PCF process.
Planning & evaluation
The MATCH approach (Mapping and Analysis for Tailored disease Control and Health system strengthening) for National Tuberculosis Programmes. MATCH supports National Tuberculosis Programmes to more effectively use resources to treat populations with ongoing tuberculosis transmission.
The MATCH approach was developed by the KIT Royal Tropical Institute to support NTPs in their efforts to enhance TB care coverage. It begins by gathering many – often underused – sources of data, for example: geographic, temporal, and demographic data. The first step in analysis then identifies places and populations with significant numbers of missed tuberculosis cases, and gaps in the pathway of care. The next step is setting this information apart and preforming further investigations through mapping, followed by spatial and temporal analysis. The final step is assessing the various data using triangulation. The result is a clear picture of what can be done to stop the transmission of tuberculosis.
The OneHealth Tool is a model to be used for supporting national strategic health planning in low- and middle-income countries. The tool facilitates an assessment of resource needs associated with key strategic activities and their associated costs, with a focus on integrated planning and strengthening health systems.
The OneHealth Tool is a computer programme for assisting countries in making informed health programming decisions. This model seeks to leverage the most useful components of the different tools that currently exist and is designed in a modular fashion allowing for program specific costing as well as health system component costing. It can be run as a stand-alone application or as part of the SPECTRUM suite of easy to use policy models which provide policymakers with an analytical tool to support the decision making process.
The KNCV Stigma Measurement Guidance is designed as a compendium guide of stigma measurement tools and approaches. The goal of this manual is to help busy people generate enough information about stigma issues to design and monitor and evaluate (M&E) stigma reduction efforts.
STP TB Stigma Assessment Implementation handbook, data collection instruments and data entry and analysis workbook
- http://www.stoptb.org/STP TB Stigma Assessment Implementation Handbook.pdf
- http://www.stoptb.org/STP TB Stigma Assessment Data Collection Instruments.pdf
- http://www.stoptb.org/STP TB Stigma Assessment Data Entry and Analysis Workbook.xlsx
Guidelines & best practices
Stigma and discrimination are recognized as some of the most commonly identified barriers to fight the TB epidemic.
KNCV’s philosophy on reducing TB stigma is to build empathy and mutual respect among communities, health care workers and TB patients. It aims to reduce the tendency to label, blame, shame and control by strengthening the awareness of our own judgements. To do so, KNCV has developed several innovative tools to understand, measure, assess and effectively address TB Stigma at its root.
Short-course TB Preventive Therapy for LTBI
IMPAACT4TB – Increasing Market and Public health outcomes through scaling up Affordable Access models of short Course preventive therapy for TB – is a four-year project introducing a new way to tackle latent Tuberculosis (TB) infection in order to slow and ultimately stop new TB cases occurring every year. This is done by identifying and providing new, shorter treatment options for people with latent TB infection.
The project prioritizes short-course TB preventive therapy for people living with HIV and children under five, and subsequently all those in close contact with TB patients in 12 high-burden countries—who represent 50 percent of the global TB burden.
TPT implementation tools: https://www.impaact4tb.org/3hp-tools/
New diagnostics and laboratory network design
All persons with active and latent TB should be detected and treated appropriately, so they cannot spread the disease further. KNCV assists in strengthening laboratory networks. Our multidisciplinary team of dedicated professionals is ready to provide assistance in various aspects of diagnostics and laboratory networks strengthening development.
A Practical Handbook for National TB Laboratory Strategic Plan Development (Updated)
This package contains the handbook, a facilitators manual, participants manual and dynamic budget excel sheets.
Digital Adherence Technology
The ASCENT project helps patients successfully complete their course of treatment through the use of digital adherence technologies and data-driven support interventions, utilizing tools such as smart pill boxes and other innovations.
Childhood TB Benchmarking tool
The KNCV Childhood TB Benchmarking Tool for policy & practice is a self-assessment tool, meant to serve as a basis for discussions, brainstorming, and strategic planning and as a tool for monitoring progress in the realization of childhood TB policies towards alignment with WHO guidelines, in the framework of a TB program.
Preventing Catastrophic Costs
The Tool to Estimate Patients’ Costs has been to
- Make economic constraints to individuals and households more apparent.
- Provide means to assess the impoverishing impact of TB on patients and their families.
- Establish an evidence-base upon which subsequent interventions can contribute to poverty reduction, increased equity in access to diagnosis and treatment, increased case detection, better treatment adherence
WHO recommends baseline and periodic measurement using an indicator termed “catastrophic total costs due to TB” to measure progress towards the high-level End TB Strategy target. Measurement is based on the conduct of surveys examining the costs to patients associated with TB, and can enable the estimation of the proportion of patients experiencing catastrophic costs. This handbook provides the necessary tools for these surveys.
New Drugs & Regimens
This document describes the steps necessary to implement the shorter regimen and the new drugs for DR-TB treatment, including diagnosis and bacterial confirmation of drug resistance, treatment regimen design, monitoring of treatment efficacy and safety, and programmatic evaluation. These steps are detailed within an M/XDR Patient Triaging Approach.
The generic guide is complemented with an Excel based implementation planning tool for the introduction of new drugs and shorter regimen. https://www.kncvtbc.org/en/downloads/tools-and-manuals/programmatic-management-of-mdr-tb/#